OWP
SGMT icon

ORG Wealth Partners’s Sagimet Biosciences SGMT Stock Holding History

ORG Wealth Partners’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,791
Closed -$122K – 645
2025
Q3 		$122K Hold
17,791
– – 0.03% 257
2025
Q2 		$143K Buy
+17,791
New +$75.1K 0.03% 203
2025
Q1 		– Sell
-21,448
Closed -$96.5K – 803
2024
Q4 		$96.5K Sell
21,448
-21,448
-50% -$109K 0.03% 183
2024
Q3 		$119K Buy
+42,896
New +$132K 0.04% 168

Other funds holding SGMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ORG Wealth Partners's SGMT Position: Q4 2025 in Review

ORG Wealth Partners sold out of Sagimet Biosciences (SGMT) in Q4 2025, closing a stake of 17,791 shares — an estimated $122K sold.

ORG Wealth Partners first reported a position in SGMT in Q3 2024 and held it in 4 quarters. The position peaked at $143K in Q2 2025. 86 funds tracked by Wall St. Rank hold SGMT as of Q4 2025.

  • ORG Wealth Partners reported no remaining Sagimet Biosciences position as of Q4 2025 after selling out during the quarter.
  • ORG Wealth Partners sold 17,791 Sagimet Biosciences shares in Q4 2025, an estimated $122K.
  • ORG Wealth Partners first reported a position in Sagimet Biosciences in Q3 2024 and held it in 4 quarters.
  • ORG Wealth Partners's Sagimet Biosciences position peaked at $143K in Q2 2025.
  • 86 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q4 2025.

Based on ORG Wealth Partners's 13F filing for Q4 2025, filed 14 Jan 2026.